{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:08:55Z","timestamp":1784095735152,"version":"3.55.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA226279"],"award-info":[{"award-number":["CA226279"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["F31HL178112"],"award-info":[{"award-number":["F31HL178112"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["GM080202"],"award-info":[{"award-number":["GM080202"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA291095"],"award-info":[{"award-number":["CA291095"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HL58012"],"award-info":[{"award-number":["HL58012"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["GM12884"],"award-info":[{"award-number":["GM12884"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Accumulating evidence indicates that evasion of apoptosis and metabolic reprogramming are necessary for pancreatic cancer growth, early invasion, and chemotherapeutic resistance. Building on our prior work, we investigated the anti-tumor potential of a rationally designed mitochondria-targeted variant of the anti-diabetic drug metformin, Mito-Met\n                    <jats:sub>10<\/jats:sub>\n                    , in cell culture models and orthotopic xenografts. Using MALDI-mass spectrometry imaging, therapeutic concentrations of fluorinated Mito-Met\n                    <jats:sub>10<\/jats:sub>\n                    were shown to preferentially localize within pancreatic tumors relative to adjacent tissue and liver. Treatment suppressed tumor growth, reduced tumor weights, and increased apoptosis in vivo. Murine and human pancreatic cancer cells demonstrated potent anti-proliferative activity, with low micromolar IC\n                    <jats:sub>50<\/jats:sub>\n                    values, and a concomitant induction of apoptotic programmed cell death in vitro. Seahorse metabolic flux analysis revealed reduced basal and ATP-linked mitochondrial respiration following Mito-Met\n                    <jats:sub>10<\/jats:sub>\n                    treatment without a compensatory increase in glycolysis. Unbiased bulk RNA sequencing revealed significant enrichment of endoplasmic reticulum stress and unfolded protein response pathways, validated by qPCR across pancreatic cancer models, with broad upregulation of UPR-associated genes, establishing that Mito-Met\n                    <jats:sub>10<\/jats:sub>\n                    activation of this stress response is conserved. Mito-Met\n                    <jats:sub>10<\/jats:sub>\n                    caused extensive cytoplasmic vacuolization, mitochondrial swelling, and loss of mitochondrial membrane potential, indicative of severe organelle damage. Mito-Met\n                    <jats:sub>10<\/jats:sub>\n                    activated PERK-eIF2\u03b1-ATF4-CHOP signaling, including upregulation of ATF4 and downstream pro-apoptotic transcriptional programs. Pharmacologic inhibition of ISR abrogated apoptotic signaling, demonstrating that PERK-eIF2\u03b1-ATF4-CHOP-mediated ISR activation functionally contributes to the anti-tumor effects of Mito-Met\n                    <jats:sub>10<\/jats:sub>\n                    . Consistent with these findings, orthotopic tumors from Mito-Met\n                    <jats:sub>10<\/jats:sub>\n                    -treated mice exhibited increased nuclear ATF4 staining compared with vehicle controls. Collectively, this study links mitochondrial stress to ER stress-associated apoptosis and identifies mitochondrial stress as a tractable vulnerability that can be manipulated to positively engage anti-tumor responses in pancreatic cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08859-y","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:55:44Z","timestamp":1779447344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitochondria-targeted metformin analogs activate the ER stress-unfolded protein response pathway to drive apoptosis in pancreatic cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7429-9218","authenticated-orcid":false,"given":"Maria","family":"Poimenidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3387-0937","authenticated-orcid":false,"given":"Jordan M.","family":"Bobek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2940-3511","authenticated-orcid":false,"given":"Donovan","family":"Drouillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8845-7452","authenticated-orcid":false,"given":"Tyler","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8900-0662","authenticated-orcid":false,"given":"Elisabeth","family":"Solis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6947-4999","authenticated-orcid":false,"given":"Chad","family":"Darnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7332-1292","authenticated-orcid":false,"given":"Donna","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8674-6391","authenticated-orcid":false,"given":"Robert F.","family":"Keyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8368-8546","authenticated-orcid":false,"given":"Mayumi","family":"Ishihara-Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0029-4291","authenticated-orcid":false,"given":"Kazuhiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5210-6497","authenticated-orcid":false,"given":"Daisy","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9180-8296","authenticated-orcid":false,"given":"Balaraman","family":"Kalyanaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-2768","authenticated-orcid":false,"given":"Brian C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5372-633X","authenticated-orcid":false,"given":"Michael B.","family":"Dwinell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"8859_CR1","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"8859_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116492","volume":"229","author":"M Espona-Fiedler","year":"2024","unstructured":"Espona-Fiedler M, Patthey C, Lindblad S, Sarr\u00f3 I, \u00d6hlund D. Overcoming therapy resistance in pancreatic cancer: new insights and future directions. Biochem Pharmacol. 2024;229:116492.","journal-title":"Biochem Pharmacol"},{"key":"8859_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-7-64","volume":"7","author":"R Hamacher","year":"2008","unstructured":"Hamacher R, Schmid RM, Saur D, Schneider G. Apoptotic pathways in pancreatic ductal adenocarcinoma. Mol Cancer. 2008;7:64.","journal-title":"Mol Cancer"},{"key":"8859_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-2-12","volume":"2","author":"JP Duffy","year":"2003","unstructured":"Duffy JP, Eibl G, Reber HA, Hines OJ. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer. 2003;2:12.","journal-title":"Mol Cancer"},{"key":"8859_CR5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1158\/1541-7786.MCR-05-0221","volume":"3","author":"DE Feldman","year":"2005","unstructured":"Feldman DE, Chauhan V, Koong AC. The unfolded protein response: a novel component of the hypoxic stress response in tumors. Mol Cancer Res. 2005;3:597\u2013605.","journal-title":"Mol Cancer Res"},{"key":"8859_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02110-3","volume":"10","author":"W Zhang","year":"2024","unstructured":"Zhang W, Shi Y, Oyang L, Cui S, Li S, Li J, et al. Endoplasmic reticulum stress\u2014a key guardian in cancer. Cell Death Discov. 2024;10:343.","journal-title":"Cell Death Discov"},{"key":"8859_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbcan.2016.12.002","volume":"1867","author":"TA Bhat","year":"2017","unstructured":"Bhat TA, Chaudhary AK, Kumar S, O\u2019Malley J, Inigo JR, Kumar R, et al. Endoplasmic reticulum-mediated unfolded protein response and mitochondrial apoptosis in cancer. Biochim Biophys Acta Rev Cancer. 2017;1867:58\u201366.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8859_CR8","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1182\/bloodadvances.2019001139","volume":"4","author":"E Ikebe","year":"2020","unstructured":"Ikebe E, Matsuoka S, Tezuka K, Kuramitsu M, Okuma K, Nakashima M, et al. Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells. Blood Adv. 2020;4:1845\u201358.","journal-title":"Blood Adv"},{"key":"8859_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/ijms24010577","volume":"24","author":"G Botrus","year":"2023","unstructured":"Botrus G, Miller RM, Uson Junior PLS, Kannan G, Han H, Von Hoff DD. Increasing stress to induce apoptosis in pancreatic cancer via the unfolded protein response (UPR). Int J Mol Sci. 2023;24:577.","journal-title":"Int J Mol Sci"},{"key":"8859_CR10","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.18632\/oncotarget.2051","volume":"5","author":"W Chien","year":"2014","unstructured":"Chien W, Ding LW, Sun QY, Torres-Fernandez LA, Tan SZ, Xiao J, et al. Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells. Oncotarget. 2014;5:4881\u201394.","journal-title":"Oncotarget"},{"key":"8859_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1408-5","volume":"10","author":"P Dauer","year":"2019","unstructured":"Dauer P, Sharma NS, Gupta VK, Durden B, Hadad R, Banerjee S, et al. ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining \u201cstemness. Cell Death Dis. 2019;10:132.","journal-title":"Cell Death Dis"},{"key":"8859_CR12","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1158\/1535-7163.MCT-15-0774","volume":"15","author":"JB Gifford","year":"2016","unstructured":"Gifford JB, Huang W, Zeleniak AE, Hindoyan A, Wu H, Donahue TR, et al. Expression of GRP78, master regulator of the unfolded protein response, increases chemoresistance in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2016;15:1043\u201352.","journal-title":"Mol Cancer Ther"},{"key":"8859_CR13","doi-asserted-by":"publisher","first-page":"E4020","DOI":"10.1073\/pnas.1616060114","volume":"114","author":"J Shen","year":"2017","unstructured":"Shen J, Ha DP, Zhu G, Rangel DF, Kobielak A, Gill PS, et al. GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant Kras-driven pancreatic tumorigenesis in mice. Proc Natl Acad Sci USA. 2017;114:E4020\u2013e9.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8859_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114737","volume":"192","author":"D Liang","year":"2021","unstructured":"Liang D, Khoonkari M, Avril T, Chevet E, Kruyt FAE. The unfolded protein response as regulator of cancer stemness and differentiation: mechanisms and implications for cancer therapy. Biochem Pharm. 2021;192:114737.","journal-title":"Biochem Pharm"},{"key":"8859_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2020.07.041","volume":"492","author":"VM Shah","year":"2020","unstructured":"Shah VM, Sheppard BC, Sears RC, Alani AW. Hypoxia: friend or foe for drug delivery in pancreatic cancer. Cancer Lett. 2020;492:63\u201370.","journal-title":"Cancer Lett"},{"key":"8859_CR16","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1158\/1535-7163.MCT-15-1021","volume":"15","author":"S Boukalova","year":"2016","unstructured":"Boukalova S, Stursa J, Werner L, Ezrova Z, Cerny J, Bezawork-Geleta A, et al. Mitochondrial targeting of metformin enhances its activity against pancreatic cancer. Mol Cancer Ther. 2016;15:2875\u201386.","journal-title":"Mol Cancer Ther"},{"key":"8859_CR17","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1158\/0008-5472.CAN-15-2534","volume":"76","author":"G Cheng","year":"2016","unstructured":"Cheng G, Zielonka J, Ouari O, Lopez M, McAllister D, Boyle K, et al. Mitochondria-targeted analogues of metformin exhibit enhanced antiproliferative and radiosensitizing effects in pancreatic cancer cells. Cancer Res. 2016;76:3904\u201315.","journal-title":"Cancer Res"},{"key":"8859_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348","author":"MR Owen","year":"2000","unstructured":"Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J. 2000;348:607\u201314.","journal-title":"Biochem J"},{"key":"8859_CR19","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02242","volume":"3","author":"WW Wheaton","year":"2014","unstructured":"Wheaton WW, Weinberg SE, Hamanaka RB, Soberanes S, Sullivan LB, Anso E, et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. Elife. 2014;3:e02242.","journal-title":"Elife"},{"key":"8859_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","volume":"2","author":"MN Pollak","year":"2012","unstructured":"Pollak MN. Investigating metformin for cancer prevention and treatment: the end of the beginning. Cancer Discov. 2012;2:778\u201390.","journal-title":"Cancer Discov"},{"key":"8859_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.canlet.2015.05.016","volume":"365","author":"G Cheng","year":"2015","unstructured":"Cheng G, Zielonka J, McAllister D, Hardy M, Ouari O, Joseph J, et al. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: role of mitochondrial bioenergetics and energy-sensing mechanism. Cancer Lett. 2015;365:96\u2013106.","journal-title":"Cancer Lett"},{"key":"8859_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105670","volume":"25","author":"M AbuEid","year":"2022","unstructured":"AbuEid M, Keyes RF, McAllister D, Peterson F, Kadamberi IP, Sprague DJ, et al. Fluorinated triphenylphosphonium analogs improve cell selectivity and in vivo detection of mito-metformin. iScience. 2022;25:105670.","journal-title":"iScience"},{"key":"8859_CR23","doi-asserted-by":"publisher","first-page":"14891","DOI":"10.1074\/jbc.RA117.001469","volume":"293","author":"KA Boyle","year":"2018","unstructured":"Boyle KA, Van Wickle J, Hill RB, Marchese A, Kalyanaraman B, Dwinell MB. Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation. J Biol Chem. 2018;293:14891\u2013904.","journal-title":"J Biol Chem"},{"key":"8859_CR24","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1002\/mc.23603","volume":"62","author":"M Shameem","year":"2023","unstructured":"Shameem M, Bagherpoor AJ, Nakhi A, Dosa P, Georg G, Kassie F. Mitochondria-targeted metformin (mitomet) inhibits lung cancer in cellular models and in mice by enhancing the generation of reactive oxygen species. Mol Carcinog. 2023;62:1619\u201329.","journal-title":"Mol Carcinog"},{"key":"8859_CR25","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-11-3928","volume":"72","author":"G Cheng","year":"2012","unstructured":"Cheng G, Zielonka J, Dranka BP, McAllister D, Mackinnon AC Jr., Joseph J, et al. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. Cancer Res. 2012;72:2634\u201344.","journal-title":"Cancer Res"},{"key":"8859_CR26","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.18632\/oncotarget.26943","volume":"10","author":"G Cheng","year":"2019","unstructured":"Cheng G, Zielonka J, Hardy M, Ouari O, Chitambar CR, Dwinell MB, et al. Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators. Oncotarget. 2019;10:3518\u201332.","journal-title":"Oncotarget"},{"key":"8859_CR27","doi-asserted-by":"publisher","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","volume":"117","author":"J Zielonka","year":"2017","unstructured":"Zielonka J, Joseph J, Sikora A, Hardy M, Ouari O, Vasquez-Vivar J, et al. Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem Rev. 2017;117:10043\u2013120.","journal-title":"Chem Rev"},{"key":"8859_CR28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49178","volume":"9","author":"E Mick","year":"2020","unstructured":"Mick E, Titov DV, Skinner OS, Sharma R, Jourdain AA, Mootha VK. Distinct mitochondrial defects trigger the integrated stress response depending on the metabolic state of the cell. eLife. 2020;9:e49178.","journal-title":"eLife"},{"key":"8859_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s40425-019-0573-5","volume":"7","author":"W Jing","year":"2019","unstructured":"Jing W, McAllister D, Vonderhaar EP, Palen K, Riese MJ, Gershan J, et al. STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models. J Immunother Cancer. 2019;7:115.","journal-title":"J Immunother Cancer"},{"key":"8859_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcmgh.2021.01.018","volume":"12","author":"EP Vonderhaar","year":"2021","unstructured":"Vonderhaar EP, Barnekow NS, McAllister D, McOlash L, Eid MA, Riese MJ, et al. STING Activated tumor-intrinsic type I interferon signaling promotes CXCR3 dependent antitumor immunity in pancreatic cancer. Cell Mol Gastroenterol Hepatol. 2021;12:41\u201358.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"8859_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40170-021-00242-z","volume":"9","author":"MK Andersen","year":"2021","unstructured":"Andersen MK, H\u00f8iem TS, Claes BSR, Balluff B, Martin-Lorenzo M, Richardsen E, et al. Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI. Cancer Metab. 2021;9:9.","journal-title":"Cancer Metab"},{"key":"8859_CR32","doi-asserted-by":"publisher","first-page":"10030","DOI":"10.1021\/ac5028534","volume":"86","author":"E Gemperline","year":"2014","unstructured":"Gemperline E, Rawson S, Li L. Optimization and comparison of multiple MALDI matrix application methods for small molecule mass spectrometric imaging. Anal Chem. 2014;86:10030\u20135.","journal-title":"Anal Chem"},{"key":"8859_CR33","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.3390\/ijms11125040","volume":"11","author":"N Zaima","year":"2010","unstructured":"Zaima N, Hayasaka T, Goto-Inoue N, Setou M. Matrix-assisted laser desorption\/ionization imaging mass spectrometry. Int J Mol Sci. 2010;11:5040\u201355.","journal-title":"Int J Mol Sci"},{"key":"8859_CR34","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.cell.2015.07.017","volume":"162","author":"LB Sullivan","year":"2015","unstructured":"Sullivan LB, Gui DY, Hosios AM, Bush LN, Freinkman E, Vander Heiden MG. Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell. 2015;162:552\u201363.","journal-title":"Cell"},{"key":"8859_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep30610","volume":"6","author":"AE Vincent","year":"2016","unstructured":"Vincent AE, Ng YS, White K, Davey T, Mannella C, Falkous G, et al. The spectrum of mitochondrial ultrastructural defects in mitochondrial myopathy. Sci Rep. 2016;6:30610.","journal-title":"Sci Rep"},{"key":"8859_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2144\/000113610","volume":"50","author":"SW Perry","year":"2011","unstructured":"Perry SW, Norman JP, Barbieri J, Brown EB, Gelbard HA. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques. 2011;50:98\u2013115.","journal-title":"Biotechniques"},{"key":"8859_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0968-0004(00)01609-1","volume":"25","author":"TG Frey","year":"2000","unstructured":"Frey TG, Mannella CA. The internal structure of mitochondria. Trends Biochem Sci. 2000;25:319\u201324.","journal-title":"Trends Biochem Sci"},{"key":"8859_CR38","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.bbamcr.2006.04.006","volume":"1763","author":"CA Mannella","year":"2006","unstructured":"Mannella CA. Structure and dynamics of the mitochondrial inner membrane cristae. Biochim Biophys Acta. 2006;1763:542\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"8859_CR39","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1126\/science.1219855","volume":"337","author":"RJ Youle","year":"2012","unstructured":"Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337:1062\u20135.","journal-title":"Science"},{"key":"8859_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.molcel.2016.05.040","volume":"63","author":"DM Booth","year":"2016","unstructured":"Booth DM, Enyedi B, Geiszt M, V\u00e1rnai P, Hajn\u00f3czky G. Redox nanodomains are induced by and control calcium signaling at the ER-mitochondrial interface. Mol Cell. 2016;63:240\u20138.","journal-title":"Mol Cell"},{"key":"8859_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119854","volume":"1872","author":"P Salu","year":"2025","unstructured":"Salu P, Tuvin D, Reindl KM. AGR2 knockdown induces ER stress and mitochondria fission to facilitate pancreatic cancer cell death. Biochim Biophys Acta Mol Cell Res. 2025;1872:119854.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"8859_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s12276-023-01137-3","volume":"56","author":"G An","year":"2024","unstructured":"An G, Park J, Song J, Hong T, Song G, Lim W. Relevance of the endoplasmic reticulum-mitochondria axis in cancer diagnosis and therapy. Exp Mol Med. 2024;56:40\u201350.","journal-title":"Exp Mol Med"},{"key":"8859_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-9861(77)90035-2","volume":"180","author":"E Cadenas","year":"1977","unstructured":"Cadenas E, Boveris A, Ragan CI, Stoppani AO. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch Biochem Biophys. 1977;180:248\u201357.","journal-title":"Arch Biochem Biophys"},{"key":"8859_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1042\/bj3530411","volume":"353","author":"D Han","year":"2001","unstructured":"Han D, Williams E, Cadenas E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem J. 2001;353:411\u20136.","journal-title":"Biochem J"},{"key":"8859_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbadis.2008.01.007","volume":"1782","author":"C Piskernik","year":"2008","unstructured":"Piskernik C, Haindl S, Behling T, Gerald Z, Kehrer I, Redl H, et al. Antimycin A and lipopolysaccharide cause the leakage of superoxide radicals from rat liver mitochondria. Biochim Biophys Acta. 2008;1782:280\u20135.","journal-title":"Biochim Biophys Acta"},{"key":"8859_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ncb0311-184","volume":"13","author":"I Tabas","year":"2011","unstructured":"Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol. 2011;13:184\u201390.","journal-title":"Nat Cell Biol"},{"key":"8859_CR47","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1038\/s41388-019-0878-3","volume":"38","author":"D Sicari","year":"2019","unstructured":"Sicari D, Fantuz M, Bellazzo A, Valentino E, Apollonio M, Pontisso I, et al. Mutant p53 improves cancer cells\u2019 resistance to endoplasmic reticulum stress by sustaining activation of the UPR regulator ATF6. Oncogene. 2019;38:6184\u201395.","journal-title":"Oncogene"},{"key":"8859_CR48","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ceb.2006.06.005","volume":"18","author":"L Zhao","year":"2006","unstructured":"Zhao L, Ackerman SL. Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol. 2006;18:444\u201352.","journal-title":"Curr Opin Cell Biol"},{"key":"8859_CR49","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00018-018-2967-9","volume":"76","author":"I Buondonno","year":"2019","unstructured":"Buondonno I, Gazzano E, Tavanti E, Chegaev K, Kopecka J, Fanelli M, et al. Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma. Cell Mol Life Sci. 2019;76:609\u201325.","journal-title":"Cell Mol Life Sci"},{"key":"8859_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110005","volume":"125","author":"H Liu","year":"2020","unstructured":"Liu H, Xiong C, Liu J, Sun T, Ren Z, Li Y, et al. Aspirin exerts anti-tumor effect through inhibiting Blimp1 and activating ATF4\/CHOP pathway in multiple myeloma. Biomed Pharmacother. 2020;125:110005.","journal-title":"Biomed Pharmacother"},{"key":"8859_CR51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/sj.cdd.4401378","volume":"11","author":"RV Rao","year":"2004","unstructured":"Rao RV, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ. 2004;11:372\u201380.","journal-title":"Cell Death Differ"},{"key":"8859_CR52","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1089\/ars.2007.1782","volume":"9","author":"JD Malhotra","year":"2007","unstructured":"Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal. 2007;9:2277\u201393.","journal-title":"Antioxid Redox Signal"},{"key":"8859_CR53","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.canlet.2019.01.034","volume":"449","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wang K, Jin Y, Sheng X. Endoplasmic reticulum proteostasis control and gastric cancer. Cancer Lett. 2019;449:263\u201371.","journal-title":"Cancer Lett"},{"key":"8859_CR54","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1158\/0008-5472.CAN-20-2633","volume":"81","author":"F Arnold","year":"2021","unstructured":"Arnold F, Gout J, Wiese H, Weissinger SE, Roger E, Perkhofer L, et al. RINT1 regulates SUMOylation and the DNA damage response to preserve cellular homeostasis in pancreatic cancer. Cancer Res. 2021;81:1758\u201374.","journal-title":"Cancer Res"},{"key":"8859_CR55","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/cmdc.202000494","volume":"15","author":"W Chen","year":"2020","unstructured":"Chen W, Hu S, Mao S, Xu Y, Guo H, Li H, et al. Discovery of mitochondrial transcription inhibitors active in pancreatic cancer cells. ChemMedChem. 2020;15:2029\u201339.","journal-title":"ChemMedChem"},{"key":"8859_CR56","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41586-025-08794-6","volume":"641","author":"C-W Chen","year":"2025","unstructured":"Chen C-W, Papadopoli D, Szkop KJ, Guan B-J, Alzahrani M, Wu J, et al. Plasticity of the mammalian integrated stress response. Nature. 2025;641:1319\u201328.","journal-title":"Nature"},{"key":"8859_CR57","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1476-5381.2010.01125.x","volume":"162","author":"F Holtrup","year":"2011","unstructured":"Holtrup F, Bauer A, Fellenberg K, Hilger RA, Wink M, Hoheisel JD. Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR). Br J Pharm. 2011;162:1045\u201359.","journal-title":"Br J Pharm"},{"key":"8859_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1366-y","volume":"10","author":"S Jia","year":"2019","unstructured":"Jia S, Xu X, Zhou S, Chen Y, Ding G, Cao L. Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways. Cell Death Dis. 2019;10:142.","journal-title":"Cell Death Dis"},{"key":"8859_CR59","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1038\/s41388-020-1260-1","volume":"39","author":"F Ricciardiello","year":"2020","unstructured":"Ricciardiello F, Gang Y, Palorini R, Li Q, Giamp\u00e0 M, Zhao F, et al. Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation. Oncogene. 2020;39:4103\u201317.","journal-title":"Oncogene"},{"key":"8859_CR60","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41575-021-00431-7","volume":"18","author":"J Encarnaci\u00f3n-Rosado","year":"2021","unstructured":"Encarnaci\u00f3n-Rosado J, Kimmelman AC. Harnessing metabolic dependencies in pancreatic cancers. Nat. Rev. Gastroenterol Hepatol. 2021;18:482\u201392.","journal-title":"Nat. Rev. Gastroenterol Hepatol"},{"key":"8859_CR61","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s43018-022-00463-1","volume":"3","author":"CJ Halbrook","year":"2022","unstructured":"Halbrook CJ, Thurston G, Boyer S, Anaraki C, Jim\u00e9nez JA, McCarthy A, et al. Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells. Nat Cancer. 2022;3:1386\u2013403.","journal-title":"Nat Cancer"},{"key":"8859_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/srep16067","volume":"5","author":"Z Niu","year":"2015","unstructured":"Niu Z, Wang M, Zhou L, Yao L, Liao Q, Zhao Y. Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer. Sci Rep. 2015;5:16067.","journal-title":"Sci Rep"},{"key":"8859_CR63","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41419-020-02779-1","volume":"11","author":"J Qi","year":"2020","unstructured":"Qi J, Zhou N, Li L, Mo S, Zhou Y, Deng Y, et al. Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer. Cell Death Dis. 2020;11:582.","journal-title":"Cell Death Dis"},{"key":"8859_CR64","doi-asserted-by":"publisher","first-page":"24980","DOI":"10.18632\/oncotarget.25166","volume":"9","author":"HV Vangapandu","year":"2018","unstructured":"Vangapandu HV, Alston B, Morse J, Ayres ML, Wierda WG, Keating MJ, et al. Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells. Oncotarget. 2018;9:24980\u201391.","journal-title":"Oncotarget"},{"key":"8859_CR65","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","volume":"29","author":"TA Yap","year":"2023","unstructured":"Yap TA, Daver N, Mahendra M, Zhang J, Kamiya-Matsuoka C, Meric-Bernstam F, et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat Med. 2023;29:115\u201326.","journal-title":"Nat Med"},{"key":"8859_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30396-3","volume":"13","author":"N Baran","year":"2022","unstructured":"Baran N, Lodi A, Dhungana Y, Herbrich S, Collins M, Sweeney S, et al. Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia. Nat Commun. 2022;13:2801.","journal-title":"Nat Commun"},{"key":"8859_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115531","volume":"211","author":"O Cadassou","year":"2023","unstructured":"Cadassou O, Jordheim LP. OXPHOS inhibitors, metabolism and targeted therapies in cancer. Biochem Pharm. 2023;211:115531.","journal-title":"Biochem Pharm"},{"key":"8859_CR68","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho WJ, Jaffee EM, Zheng L. The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities. Nat Rev Clin Oncol. 2020;17:527\u201340.","journal-title":"Nat Rev Clin Oncol"},{"key":"8859_CR69","doi-asserted-by":"crossref","unstructured":"Koltai T, Reshkin SJ, Carvalho TMA, Di Molfetta D, Greco MR, Alfarouk KO, et al. Resistance to gemcitabine in pancreatic ductal adenocarcinoma: a physiopathologic and pharmacologic review. Cancers. 2022;14:2486.","DOI":"10.3390\/cancers14102486"},{"key":"8859_CR70","doi-asserted-by":"publisher","first-page":"61","DOI":"10.26502\/jcsct.5079146","volume":"6","author":"X Zhao","year":"2022","unstructured":"Zhao X, Li Z, Gu Z. A new era: tumor microenvironment in chemoresistance of pancreatic cancer. J Cancer Sci Clin Ther. 2022;6:61\u201386.","journal-title":"J Cancer Sci Clin Ther"},{"key":"8859_CR71","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.freeradbiomed.2011.11.001","volume":"52","author":"P Mukhopadhyay","year":"2012","unstructured":"Mukhopadhyay P, Horv\u00e1th B, Zsengell\u00e9r Z, Zielonka J, Tanchian G, Holovac E, et al. Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radic Biol Med. 2012;52:497\u2013506.","journal-title":"Free Radic Biol Med"},{"key":"8859_CR72","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1369\/0022155412446227","volume":"60","author":"ZK Zsengell\u00e9r","year":"2012","unstructured":"Zsengell\u00e9r ZK, Ellezian L, Brown D, Horv\u00e1th B, Mukhopadhyay P, Kalyanaraman B, et al. Cisplatin nephrotoxicity involves mitochondrial injury with impaired tubular mitochondrial enzyme activity. J Histochem Cytochem. 2012;60:521\u20139.","journal-title":"J Histochem Cytochem"},{"key":"8859_CR73","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1158\/0008-5472.CAN-07-5714","volume":"68","author":"RF Hwang","year":"2008","unstructured":"Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008;68:918\u201326.","journal-title":"Cancer Res"},{"key":"8859_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102437","volume":"4","author":"RF Keyes","year":"2023","unstructured":"Keyes RF, McAllister D, Dwinell MB, Smith BC. Synthesis of fluorinated triphenylphosphonium analogs that improve cancer cell selectivity and in vivo detection. STAR Protoc. 2023;4:102437.","journal-title":"STAR Protoc"},{"key":"8859_CR75","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1055\/a-1681-4544","volume":"05","author":"R Bardovskyi","year":"2021","unstructured":"Bardovskyi R, Fabre M, Ronco C, Benhida R. Mild biamidine-transfer conditions for the synthesis of aliphatic biguanides. SynOpen. 2021;05:314\u201320.","journal-title":"SynOpen"},{"key":"8859_CR76","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/nprot.2009.171","volume":"4","author":"MP Kim","year":"2009","unstructured":"Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc. 2009;4:1670\u201380.","journal-title":"Nat Protoc"},{"key":"8859_CR77","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1158\/0008-5472.CAN-14-2645","volume":"75","author":"I Roy","year":"2015","unstructured":"Roy I, McAllister DM, Gorse E, Dixon K, Piper CT, Zimmerman NP, et al. Pancreatic cancer cell migration and metastasis is regulated by chemokine-biased agonism and bioenergetic signaling. Cancer Res. 2015;75:3529\u201342.","journal-title":"Cancer Res"},{"key":"8859_CR78","doi-asserted-by":"publisher","first-page":"e90400","DOI":"10.1371\/journal.pone.0090400","volume":"9","author":"I Roy","year":"2014","unstructured":"Roy I, Zimmerman NP, Mackinnon AC, Tsai S, Evans DB, Dwinell MB. CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. PLoS One. 2014;9:e90400.","journal-title":"PLoS One"},{"key":"8859_CR79","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels PA, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A, et al. The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol. 2020;38:276\u20138.","journal-title":"Nat Biotechnol"},{"key":"8859_CR80","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417\u20139.","journal-title":"Nat Methods"},{"key":"8859_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"8859_CR82","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16:284\u20137.","journal-title":"Omics"},{"key":"8859_CR83","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic M, Beavers D, Conley P, Gong C, Gillespie M, Griss J, et al. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 2024;52:D672\u2013d8.","journal-title":"Nucleic Acids Res"},{"key":"8859_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-12005-7","volume":"15","author":"D Drouillard","year":"2025","unstructured":"Drouillard D, Halyko M, Cinquegrani E, Poimenidou M, Emosivbe M, McAllister D, et al. CXCL12 chemokine dimer signaling modulates acute myelogenous leukemia cell migration through altered receptor internalization. Sci Rep. 2025;15:26625.","journal-title":"Sci Rep"},{"key":"8859_CR85","doi-asserted-by":"crossref","unstructured":"Divakaruni AS, Paradyse A, Ferrick DA, Murphy AN, Jastroch M. Chapter Sixteen - Analysis and interpretation of microplate-based oxygen consumption and pH data. In: Murphy AN, Chan DC, editors. Methods in Enzymology. 547: Academic Press; 2014. pp. 309\u201354.","DOI":"10.1016\/B978-0-12-801415-8.00016-3"},{"key":"8859_CR86","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265\u201375.","journal-title":"J Biol Chem"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08859-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08859-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08859-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:01:29Z","timestamp":1784095289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08859-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8859"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08859-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MBD is a co-founder and has ownership and financial interests in Protein Foundry, LLC, and XLock Biosciences, Inc. BK has a composition-of-matter and application-of-use patent on the manufacture and use of mito-metformin in cancer (USPTO 62\/779,795). Chemical modifications of mitochondria-targeted compounds, including those described herein, are covered by a provisional US Patent, U.S. Application No. 63\/285,374, to MBD, RFK, and BCS. MP was supported in part by a fellowship award from the Medical College of Wisconsin Cancer Center. DD, JMB, DS, and BCS have received financial support from the NIH. All other authors declare no potential financial conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All procedures and animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) at Medical College of Wisconsin and performed in accordance with the approved Animal Use Agreement AUA000076.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"643"}}